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Abstract
We present here a Finnish nemaline myopathy family with a dominant mutation in the skeletal muscle α-actin gene, p.(Glu85Lys), segregating
in three generations. The index patient, a 5-year-old boy, had the typical form of nemaline myopathy with congenital muscle weakness and motor
milestones delayed but reached, while his mother never had sought medical attention for her very mild muscle weakness, and his maternal
grandmother had been misdiagnosed as having myotonic dystrophy. This illustrates the clinical variability in nemaline myopathy.
© 2017 Elsevier B.V. All rights reserved.
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1. Introduction
To date, more than 200 different pathogenic variants have
been identified in the α-actin 1 gene (ACTA1). The vast majority,
over 170 of these disease-causing variants, cause nemaline
myopathy (NM), but variants in ACTA1 may cause a wide
spectrum of myopathies, clinically varying from lethal fetal
akinesia to disorders with mild muscle weakness [1,2]. In addition
to NM, ACTA1 myopathies include actin myopathy, cap myopathy,
congenital fibre-type disproportion, core-rod myopathy,
intranuclear rod myopathy, zebra body myopathy, and progressive
scapuloperoneal myopathy. Recently, dominant mutations in
ACTA1 have been identified as the cause of a dominant distal
myopathy with nemaline rods [3–11]. Correspondingly, the
muscle histopathology of patients with ACTA1 mutations is
diverse. The spectrum encompasses nemaline bodies, actin
filament aggregates, core structures, caps, fibre-type disproportion,
zebra bodies, and dystrophic features. In some patients with
muscle weakness, only minimal histological changes have been
detected. Diagnostics based on muscle histopathology can thus
be very difficult; the clinical and histological features overlap
between entities, and one single muscle biopsy may show a
combination of different histopathologies [9,12].
The most common myopathy related to ACTA1 is NM. We
have estimated that variants in ACTA1 cause 23% of NM cases.
ACTA1 variants are the most common cause of sporadic NM,
and a common cause of very severe (lethal) forms with fetal
akinesia also. Most of the pathogenic variants in ACTA1 are
dominant (90%) and a majority of the dominant variants have
arisen de novo. Of the sporadic cases with ACTA1 variants,
approximately 85% have been shown to be caused by de novo
variants. Autosomal recessive variants are rarer (10%). Domi-
nant variants inherited across two or more generations have
been identified in less than 5% of ACTA1 families, while mosa-
icism has been observed in a couple of families [12,13].
2. Clinical features in the three affected family members
2.1. Clinical findings and molecular diagnostic investigations
In the Finnish family described here, a 5-year-old boy under-
went investigations because of generalised muscle weakness.
His motor milestones were delayed but reached. He was a bright
boy who did well at school. The clinical examination showed
lumbar hyperlordosis, myopathic facies and high-arched palate
(Fig. 1A–D). Muscle bulk was small and weakness was of grade
4 on the MRC scale in all muscle groups, while the facial
muscles were weaker, and the neck flexors showed weakness of
grade 2. A diagnosis of NM was made on the basis of muscle
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biopsy findings including the presence of nemaline bodies
(Fig. 2A). His NM was classified as typical.
The genetic cause was subsequently sought for by
sequencing of the nebulin gene for the known Finnish variants,
and of the entire ACTA1, resulting in the identification of a
missense variant, p.(Glu85Lys), in ACTA1. This variant had
previously been identified in two unrelated NM patients as de
novo mutations, and thus the variant was known to be
pathogenic [14]. DNA samples of the family were subsequently
sequenced to check the segregation of the variant.
The same variant was identified in the mother of the index
patient, and she was then clinically examined. She was found to
have mild weakness of the neck flexors, grip strength and
quadriceps muscles, consistent with the mild form of NM
(Fig. 1E). A detailed history revealed that she had always had
slight motor difficulties although she had reached her motor
milestones without any observed delay. She had, however, never
sought medical attention for her motor problems. Her biopsy,
performed at the age of 36 years, showed numerous nemaline
bodies (Fig. 2B).
After identification of the dominantly inherited mutation in
the family, a DNA sample of the boy’s deceased maternal
grandmother was also sequenced for the variant. She had
presented at the age of 44 years with muscle weakness. She had
always worn high heels and had contractures of the Achilles
tendons. EMG showed myopathic features while CK levels
were normal. At the time, she was misdiagnosed as having
myotonic dystrophy. The grandmother also had arthrosis, gall
stones, hypothyreosis, high blood pressure and kidney stones.
She died of cancer of the urinary tract at the age of 68 years. On
re-examination of the muscle biopsy, it was found to show
nemaline bodies (Fig. 2C). Her diagnosis was confirmed by the
identification of the same ACTA1 variant in her. She can in
retrospect be thought to have had the mild form of NM. Her
father was said to have had weak legs, and he had to use his
arms for getting up from a chair.
2.2. Histology
Muscle biopsy of the vastus lateralis had been done in the
three affected family members. In all three biopsies, Gömöri
trichrome staining revealed abundant cytoplasmic nemaline
bodies (Fig. 2A–C). Fibre size variability (Fig. 2D–F) was less
apparent in the proband’s biopsy (Fig. 2D) than in mother’s (E)
and grandmother’s (F) biopsies. Only the grandmother’s biopsy
showed a clearly increased number of internal nuclei as well as
split fibres (Fig. 2F). In addition, on NADH staining (Fig. 2G–I)
a few core-like structures were seen in the biopsy of the
grandmother (Fig. 2I), while core structures were not seen in
the biopsies of the proband or mother (Fig. 2G,H). Myosin
double staining of myosin heavy chain fast and slow (Fig. 2J,K)
showed type 1 fibre uniformity and abnormal fibre size
variability in the proband (Fig. 2J). The mother’s biopsy
showed mild fibre type 1 predominance, type 1 fibre atrophy
and type 2 fibre hypertrophy. In addition, several immature
hybrid fibres were present (Fig. 2K). The grandmother’s biopsy
is no longer available for double staining. However, the
pathologist’s report mentions fibre type 1 predominance and
atrophy.
Electron microscopy was performed on muscle samples
from the proband and mother. Both had typical
intracytoplasmic nemaline rods. No intranuclear rods were
found.
3. Variant prediction using the in silico tool
The ACTA1 variant p.(Glu85Lys) was analysed using the
HOPE tool (http://www.cmbi.ru.nl/hope), which predicts the
3D model of the protein of interest using WHAT IF web
services. HOPE predicts how the variant affects the protein
structure and function.Amino acid residue 85 is a glutamic acid
in wild-type (wt) actin, located on the surface of the protein,
this residue being 100 % conserved. The glutamic acid at
position 85 forms a hydrogen bond with threonine at position
Fig. 1. The proband (A–D): a 5-year-old boy, with myopathic facies, slender
build and hyperlordosis. His mother (E) has slight hypomimia and mild
weakness of the neck flexors, grip strength and quadriceps muscles.
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128, and a salt bridge with lysine at position 120. The function
of the residue at position 85 is not known, neither is it known
whether Glu85 binds to other molecules. The variant discussed
here changes a glutamine to a lysine, p.(Glu85Lys). Glutamic
acid is smaller than lysine, and it is positively charged, while
lysine is negatively charged. Lysine instead of glutamine at
position 85 is unable to form the hydrogen bond and the salt
bridge present in wt actin. The variant therefore changes the
structure of the protein and likely disrupts the correct function
of the protein.
Fig. 2. Histological findings in muscle biopsies from the proband, the mother and the grandmother. Gömöri trichrome staining (A–C): in all three biopsies,
aggregations of nemaline bodies are seen as dark-staining areas. H&E staining (D–F): fibre size variability is most apparent in the mother’s (E) and grandmother’s
(F) biopsies. NADH staining (G-I) shows fibre type uniformity in the proband’s (G) and the grandmother’s (I) biopsies as only strongly reacting type I fibres are
present. The grandmother’s biopsy additionally reveals a few core-like centrally unstained fibres. In the mother’s biopsy (H), NADH staining is unremarkable. MHC
double staining (J,K): fast (red) and slow (brown) demonstrates fibre type 1 uniformity in the proband’s biopsy (J). The mother’s biopsy (K) shows slight
predominance and atrophy of type 1 fibres. Some hypertrophic type 2 fibres are seen, as well as red-brown immature hybrid fibres.
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4. Discussion
To our knowledge, the family described here is the first NM
family with a pathogenic dominant variant of ACTA1 present
in three generations. In this Finnish NM family, the variant
p.(Glu85Lys) was found to be present in a 5-year-old boy, his
mother and his maternal grandmother, who had probably inherited
it from her father. All these family members were found to
have NM, verified by muscle biopsy.
The same variant has been described in the literature as a de
novo mutation in two unrelated patients of American origin
[14]. Thus, the variant was known to be pathogenic, and therefore,
further mutational analyses were not performed in the current
family.
Both of the patients described in the previous publication
[14] were boys with the typical form of NM. Hypotonia was
noted at the age of three months in patient 349-1. At the age of
three years he was ambulant, and had no respiratory or feeding
issues at the time. Electron microscopy was not performed. The
second patient, 349-2, showed hypotonia at birth. His motor
milestones were delayed; he achieved sitting at the age of 9
months and walking at 16 months. He, too, was ambulant at the
age of three years and did not have feeding or respiratory
problems at the time. His muscle biopsy showed marked type 1
fibre predominance, moderate fibre size variability, scattered
and group atrophy, and numerous nemaline bodies [14].
The largest single actinopathy pedigree published to date
depicts an extended family of six generations with a dominant,
progressive scapuloperoneal neuromuscular disorder, shown to
be caused by the ACTA1 variant p.(Glu197Asp). No nemaline
rods or actin aggregates were observed in the muscle biopsies
examined [10].
The family described here is one more example of how the
clinical and histological features of NM may be variable, even
between family members sharing the same mutation. This vari-
ability is likely due to both environmental and genetic modify-
ing factors.
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